Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033377 (
prolapse
)
11,717
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is known that the CXBK inbred strain of mouse is deficient in mu1 opioid receptors, whereas the strain has a
delta opioid receptor
population that is less consistently altered. In the present study, we compared physical dependence on morphine between CXBK and C57BL/6 mice. Both strains of mice were treated with morphine-admixed food for 5 days. During the treatment, the two strains of mice showed no signs of toxicity. There was no significant difference in morphine intake during the treatment between CXBK and C57BL/6 mice. After the treatment, the withdrawal was precipitated by injecting naloxone (0.01-30 mg/kg, s.c.). CXBK mice showed weight loss, diarrhea and
ptosis
, but not jumping and body shakes after low dose of naloxone. Whereas, C57BL/6 mice showed weight loss, diarrhea,
ptosis
, body shakes and jumping. These results suggest that naloxone-precipitated weight loss, diarrhea and
ptosis
may be mediated by mu2 and/or
delta opioid receptor
, while naloxone-precipitated jumping and body shakes may be mediated by mu1 opioid receptors.
...
PMID:The role of mu1 receptor in physical dependence on morphine using the mu receptor deficient CXBK mouse. 131 92